On July 16, 2025, Core Laboratories (CLB, Financial) saw an update in its stock outlook as Stifel analyst Stephen Gengaro modified the price target of the company. The new price target has been set at $12.00 USD, a decrease from the previous target of $13.00 USD, marking a 7.69% reduction.
Stifel's adjustment in the price target is a part of maintaining their current rating for Core Laboratories (CLB, Financial) at "Hold," consistent with prior assessments. The adjustment signifies a realignment of expectations for the company's stock performance, reflecting current market conditions and core business metrics.
Investors in Core Laboratories (CLB, Financial) should take note of this revised price target as it offers insights into the anticipated financial trajectory of the company according to Stifel's latest analysis. The stock trades on the NYSE under the ticker CLB, and the analysis is denominated in USD.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 5 analysts, the average target price for Core Laboratories Inc (CLB, Financial) is $14.40 with a high estimate of $19.00 and a low estimate of $10.00. The average target implies an upside of 25.11% from the current price of $11.51. More detailed estimate data can be found on the Core Laboratories Inc (CLB) Forecast page.
Based on the consensus recommendation from 5 brokerage firms, Core Laboratories Inc's (CLB, Financial) average brokerage recommendation is currently 3.0, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Core Laboratories Inc (CLB, Financial) in one year is $19.88, suggesting a upside of 72.72% from the current price of $11.51. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Core Laboratories Inc (CLB) Summary page.
